Cite
COX-2 inhibitors ameliorate experimental autoimmune encephalomyelitis through modulating IFN-γ and IL-10 production by inhibiting T-bet expression
MLA
Wei Tang, et al. “COX-2 Inhibitors Ameliorate Experimental Autoimmune Encephalomyelitis through Modulating IFN-γ and IL-10 Production by Inhibiting T-Bet Expression.” Journal of Neuroimmunology, vol. 186, May 2007, pp. 94–103. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7391478ce6ad4a872bb9d24c60a1977a&authtype=sso&custid=ns315887.
APA
Wei Tang, Hui Wang, Jia Ni, Yun-Feng Fu, Ming-Wei Wang, Xiang-Gen Zhong, Jin Ren, Jianping Zuo, Yi-Na Zhu, Ying-Yi Shu, & Yi-Fu Yang. (2007). COX-2 inhibitors ameliorate experimental autoimmune encephalomyelitis through modulating IFN-γ and IL-10 production by inhibiting T-bet expression. Journal of Neuroimmunology, 186, 94–103.
Chicago
Wei Tang, Hui Wang, Jia Ni, Yun-Feng Fu, Ming-Wei Wang, Xiang-Gen Zhong, Jin Ren, et al. 2007. “COX-2 Inhibitors Ameliorate Experimental Autoimmune Encephalomyelitis through Modulating IFN-γ and IL-10 Production by Inhibiting T-Bet Expression.” Journal of Neuroimmunology 186 (May): 94–103. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7391478ce6ad4a872bb9d24c60a1977a&authtype=sso&custid=ns315887.